Skip to main content
. 2018 Oct 18;19(10):3219. doi: 10.3390/ijms19103219
CAK CDK-activating kinase
CDK Cyclin-dependent kinase
CDKN2A Cyclin-dependent kinase Inhibitor 2A
CLL Chronic lymphocytic leukemia
CMGC CDKs, MAPKs, Gsk3β, and CDK-like kinases
CTD C-Terminal Domain
DYRK Dual-specificity tyrosine-regulated kinase
ELL2 Elongation Factor for RNA Polymerase II
FACT protein Facilitates chromatin transcription
FDA US Food and Drug Administration
FOLFIRINOX FOL = Folinic acid, L = Leucovorin, F = 5-FU = 5-Fluorouracil, IRIN = Irinotecan, OX = Oxaliplatin
FoxM1 Forkhead box protein M1
GADD45 Growth Arrest and DNA Damage-inducible protein
GSK3β Glycogen synthase kinase-3 β
hESC Human embryonic stem cells
hiPSC Human induced pluripotent stem cells
INK4 Inhibitor of Cyclin-Dependent Kinase 4
MAPK Mitogen-activated protein kinase
MAT1 Menage á trois 1
Mcl-1 Myeloid leukaemia cell differentiation protein 1
MED12 Mediator complex subunit 12
MED13 Mediator complex subunit 13
MPK7 Mitogen-activated protein kinase 7
mTOR Mechanistic target of rapamycin
NSCLC Non-small cell lung cancer
PanIN Pancreatic intraepithelial neoplasia
PDAC Pancreatic ductal adenocarcinoma
pTEFb Positive transcription elongation factor b
RalA RAS-Like Protein A
Rb Retinoblastoma protein
RNA Pol II RNA polymerase II
ROS Reactive oxygen species
TAK Tat-associated kinase
TCF/LEF T-cell factor/lymphoid enhancer factor
TF Transcription factor
TFIIH Transcription factor II H
TP53 Tumour protein p53
TPKII Tau protein kinase II
TRAIL-R1/2 Tumour necrosis factor-related, apoptosis-inducing ligand receptors 1/2